LEXARIA BIOSCIENCE CORP. Proceeds from (Repayments of) Debt
LEXARIA BIOSCIENCE CORP. (LEXX) reported Proceeds from (Repayments of) Debt of -$50.00 thousand for the 12-month period ending 2017-08-31, per its 10-K filed 2017-11-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2017-11-27
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for the quarter ending 2016-08-31 was $50.00K.
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for the quarter ending 2015-11-30 was $0.00.
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for the quarter ending 2015-08-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for the quarter ending 2014-11-30 was -$776.94K.
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for fiscal 2017 was -$50.00K, a 152.63% decline from fiscal 2016.
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for fiscal 2016 was $95.00K.
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for fiscal 2015 was -$98.74K.
- LEXARIA BIOSCIENCE CORP. proceeds from (repayments of) debt for fiscal 2014 was -$306.89K.
| Period end | Proceeds from (Repayments of) Debt 3 month | Proceeds from (Repayments of) Debt 6 month | Proceeds from (Repayments of) Debt 9 month | Proceeds from (Repayments of) Debt 10 month | Proceeds from (Repayments of) Debt 12 month | Proceeds from (Repayments of) Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-08-31 | -$50.00K 10-K · filed 2017-11-27 | |||||
| 2016-08-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-27 | $95.00K 10-K · filed 2017-11-27 | ||||
| 2016-05-31 | $45.00K 10-Q · filed 2016-07-13 | |||||
| 2016-02-29 | $0.00 10-Q · filed 2016-04-13 | |||||
| 2015-11-30 | $0.00 10-Q · filed 2016-01-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-29 | ||||
| 2015-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | -$98.74K 10-K · filed 2016-11-29 | ||||
| 2015-05-31 | -$98.74K 10-Q · filed 2016-07-13 | |||||
| 2015-02-28 | -$98.74K 10-Q · filed 2016-04-13 | |||||
| 2014-11-30 | -$776.94K 10-Q · filed 2016-01-08 | -$680.68K derived: sum of 2 quarters · filed 2016-01-08 | ||||
| 2014-08-31 | $96.26K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | -$306.89K 10-KT · filed 2014-12-09 | -$306.89K 10-K · filed 2015-11-27 | |||
| 2014-07-31 | -$103.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$328.06K derived: sum of 2 quarters · filed 2014-11-14 | -$278.06K 10-Q · filed 2014-11-14 | |||
| 2014-05-31 | -$403.15K 10-Q · filed 2015-07-14 | |||||
| 2014-04-30 | -$224.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | -$174.24K 10-Q · filed 2014-06-12 | ||||
| 2014-02-28 | $0.00 10-Q · filed 2015-04-14 | |||||
| 2014-01-31 | $50.00K 10-Q · filed 2014-03-12 | |||||
| 2013-11-30 | $0.00 10-Q · filed 2015-01-14 | |||||
| 2013-10-31 | -$30.03K derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09 | -$107.20K derived: sum of 2 quarters · filed 2014-12-09 | -$198.43K derived: sum of 3 quarters · filed 2014-12-09 | -$365.36K 10-KT · filed 2014-12-09 | ||
| 2013-08-31 | -$348.00K 10-KT · filed 2014-12-09 | |||||
| 2013-07-31 | -$77.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$168.41K derived: sum of 2 quarters · filed 2014-11-14 | -$335.33K 10-Q · filed 2014-11-14 | -$347.83K derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2013-04-30 | -$91.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | -$258.16K 10-Q · filed 2014-06-12 | -$270.65K derived: sum of 3 quarters · filed 2014-06-12 | -$220.65K derived: sum of 4 quarters · filed 2014-06-12 | ||
| 2013-01-31 | -$166.93K 10-Q · filed 2014-03-12 | -$179.42K derived: sum of 2 quarters · filed 2014-03-12 | -$129.42K derived: sum of 3 quarters · filed 2014-03-12 | -$79.42K derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-10-31 | -$12.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $37.50K derived: sum of 2 quarters · filed 2014-01-24 | $87.50K derived: sum of 3 quarters · filed 2014-01-24 | $87.50K 10-K · filed 2014-01-24 | -$12.50K 10-K · filed 2013-01-29 | |
| 2012-07-31 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10 | $100.00K derived: sum of 2 quarters · filed 2013-09-10 | $100.00K 10-Q · filed 2013-09-10 | -$231.44K derived: sum of 4 quarters · filed 2013-09-10 | ||
| 2012-04-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-12 | $50.00K 10-Q · filed 2013-06-12 | -$281.44K derived: sum of 3 quarters · filed 2013-06-12 | -$414.09K derived: sum of 4 quarters · filed 2013-06-12 | ||
| 2012-01-31 | $0.00 10-Q · filed 2013-03-13 | -$331.44K derived: sum of 2 quarters · filed 2013-03-13 | -$464.09K derived: sum of 3 quarters · filed 2013-03-13 | $104.99K derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-10-31 | -$331.44K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$464.09K derived: sum of 2 quarters · filed 2013-01-29 | $104.99K derived: sum of 3 quarters · filed 2013-01-29 | $0.00 10-K · filed 2013-01-29 | $329.90K 10-K · filed 2012-01-30 | |
| 2011-07-31 | -$132.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-12 | $436.43K derived: sum of 2 quarters · filed 2012-09-12 | $331.44K 10-Q · filed 2012-09-12 | $421.44K derived: sum of 4 quarters · filed 2012-09-12 | ||
| 2011-04-30 | $569.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-07 | $464.09K 10-Q · filed 2012-06-07 | $554.09K derived: sum of 3 quarters · filed 2012-06-07 | |||
| 2011-01-31 | -$104.99K 10-Q · filed 2012-03-13 | -$14.99K derived: sum of 2 quarters · filed 2012-03-13 | ||||
| 2010-10-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $165.00K 10-K · filed 2012-01-30 | ||||
| 2010-07-31 | $75.00K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |